Trailing-twelve-month (TTM) revenue is $1.79 Billion with a year-over-year growth of +4.25%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $384,623,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q2 FY2026Period ended 2025-12-31 | $464,057,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-29 |
| Q3 FY2026Period ended 2026-03-31 | $453,246,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q4 FY2026Period ended 2026-06-30 | $484,058,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-21 |
| TTM revenue | $1,785,984,000 |
Current P/S: $3,273,539,865 market capitalization ÷ $1,785,984,000 TTM revenue = 1.83x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:35:13.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $484.06M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:37:36.549Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Product | $873M | N/A | $959M | $1.2B | $1.3B | $1.3B |
| Products | N/A | $897M | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Americas | $667M | N/A | N/A | N/A | N/A | N/A |
| APAC | N/A | $228M |
$1.79B
$1.79 Billion
+4.25%
vs. $1.71B a year ago (TTM)
+9.26%
5 Year compound annual growth rate
1 Year
+4.25%
3 Year
+11.79%
5 Year
+9.26%
10 Year
+7.97%
15 Year
+6.90%
20 Year
+7.10%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.79B | +$72.82M | +4.25% |
| 2025 | $1.71B | +$174.41M | +11.33% |
| 2024 | $1.54B | +$260.33M | +20.36% |
| 2023 | $1.28B | +$95.19M | +8.04% |
| 2022 | $1.18B | +$36.33M | +3.17% |
| 2021 |
TTM Growth
+4.25%
3-Year CAGR
+11.79%
5-Year CAGR
+9.26%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:37:36.549Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| Service | $274M | N/A | $320M | $331M | $390M | $441M |
|---|
| Services | N/A | $286M | N/A | N/A | N/A | N/A |
|---|
| $268M |
| $323M |
| $349M |
| Asia Pacific | $229M | N/A | N/A | N/A | N/A | N/A |
|---|
| E M E A | $251M | N/A | N/A | N/A | N/A | N/A |
|---|
| Mexico | N/A | N/A | N/A | N/A | $276M | $99M |
|---|
| Other Americas | N/A | N/A | N/A | N/A | $155M | $206M |
|---|
| Other EMEA | N/A | N/A | N/A | N/A | $50M | $78M |
|---|
| Total Americas | N/A | $625M | $757M | $1.0B | $1.0B | $917M |
|---|
| Total EMEA | N/A | $330M | $331M | $296M | $432M | $595M |
|---|
| United States | N/A | N/A | N/A | N/A | $590M | $612M |
|---|
| $1.15B |
| ($19.14M) |
| (1.64%) |
| 2020 | $1.17B | ($16.07M) | (1.36%) |
| 2019 | $1.18B | +$92.83M | +8.52% |
| 2018 | $1.09B | +$128.34M | +13.35% |
| 2017 | $960.95M | +$131.29M | +15.82% |
